Mark Schoenberg - 18 Mar 2024 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
18 Mar 2024
Net transactions value
-$168,600
Form type
4
Filing time
20 Mar 2024, 16:38:32 UTC
Previous filing
02 Feb 2024
Next filing
11 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale $168,600 -12,000 -7.9% $14.05 139,437 18 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A portion of the cash receipts will be used for federal income tax purposes